Carcinoembryonic antigen (CEA) is not normally produced in significant quantities after birth
but is elevated in colorectal cancer. The aim of this review was to define the current role of …

Treatments for colorectal cancer (CRC) of all stages have evolved considerably over the
past two decades, resulting in improved long-term outcomes. After curative treatment …

Background Lung metastasectomy in the treatment of advanced colorectal cancer has been
widely adopted without good evidence of survival or palliative benefit. We aimed to test its …

Aim Lung metastases from colorectal cancer are resected in selected patients in the belief
that this confers a significant survival advantage. It is generally assumed that the 5‐year …

Follow‐up strategies for patients treated for non‐metastatic colorectal cancer - Jeffery, M - 2019
| Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Background The pathogenesis of colorectal cancer recurrence after a curative resection
remains poorly understood. A yet-to-be accounted for variable is the composition and …

The peritoneum is a common site of dissemination for colorrectal cancer, with a poorer
prognosis than other sites of metastases. In the last two decades, it has been considered as …

Anastomotic leak (AL) remains a potentially life-threatening sequela of colorectal surgery
impacting on mortality, short-and long-term morbidity, quality of life, local recurrence (LR) …

Aim We wanted to examine survival in patients with resected colorectal cancer (CRC) whose
lung metastases are or are not resected. Methods Teams participating in the study of …

1 We recommend post-surgery endoscopic surveillance for CRC patients after intent-to-cure
surgery and appropriate oncological treatment for both local and distant disease. Strong …